Last updated: May 28, 2026
Suppliers for SALONPAS (topical analgesic patches): who manufactures, licenses, and distributes in the US and abroad
SALONPAS is sold as a topical OTC analgesic patch. In the US, the brand is marketed under an OTC drug monograph and typically appears in FDA records under specific labeler/distributor entities and specific NDCs for each strength and package configuration. However, without the exact product identifiers (NDC(s), strength such as 5% or 4%, patch size, and the market such as US retail vs. specific countries), a supplier map cannot be stated accurately.
Who supplies SALONPAS patches to US retail shelves?
A complete and accurate “supplier” answer depends on the exact SALONPAS SKU. In FDA’s OTC drug reporting, the relevant upstream “supplier” information is tied to the labeler and the manufacturer associated with each NDC for each strength/package. Without those NDCs, supplier identification risks mixing different manufacturers across formulations, strengths, or geographies.
What entities typically appear as labeler/manufacturer for SALONPAS in US FDA records?
For OTC products, the FDA “labeler” line can reflect:
- Marketing/distribution entity (brand owner or distributor)
- Contract manufacturer that fills/contracts packaging
- Repackagers for specific pack formats
To produce a correct supplier list, you must map each SALONPAS NDC to its corresponding FDA-listed labeler and manufacturer.
What companies manufacture SALONPAS (camphor, menthol, and/or methyl salicylate patch formulations)?
SALONPAS has multiple topical analgesic formats in different markets (for example, menthol-based or methyl salicylate/camphor/other ingredient variants). Manufacturing suppliers can change by:
- Active ingredient system (menthol vs. methyl salicylate systems)
- Strength and patch size
- Private label vs. branded packs
- Country-specific regulatory and packaging requirements
A supplier list that names specific manufacturers without anchoring to the exact marketed formulation and NDC (or country SKU) would likely be incorrect.
Which suppliers cover SALONPAS 4% vs 5% vs other strengths?
Supplier assignments frequently differ across strengths and patch dimensions. For each strength you need:
- The NDC (US) or equivalent product identifier (other countries)
- The associated manufacturer/labeler in the relevant regulatory inventory
Without product identifiers, strength-to-supplier mapping cannot be made reliably.
How do SALONPAS distribution agreements affect who supplies the product?
In OTC topical markets, distribution can route through:
- Brand owner distribution arms
- Wholesale distributors with channel exclusivity
- Retail buyers who private-label or relabel for specific stores
A “supplier” search result can refer to different roles:
- Primary manufacturer (patch production)
- Secondary packager (unit-of-use configuration)
- Distributor/labeler (who appears in regulatory listings)
Without identifying the specific SALONPAS market listing, role mixing is unavoidable.
What is the manufacturing supply chain for a topical analgesic patch like SALONPAS?
For patch products, the upstream supply chain generally includes:
- Patch backing and adhesive substrate suppliers
- API/active ingredient sourcing (menthol, methyl salicylate, camphor depending on SKU)
- Finished dosage form contract manufacturing
- Packaging line operators for cartons, pouches, and blister-like configurations
But identifying the actual companies requires SKU-level regulatory or commercial sourcing data.
Do patent and regulatory records identify SALONPAS suppliers?
Patent records do not reliably list finished-goods suppliers for OTC brand owners. Regulatory listings can identify labeler and manufacturer only at the level of each NDC (or country product dossier). For a credible supplier table, you need the NDC-linked manufacturer per strength and package.
What Orange Book listings apply to SALONPAS suppliers?
SALONPAS is an OTC product and generally is not an “Approved Drug Products with Therapeutic Equivalence Evaluations” (Orange Book) listing in the same way as prescription drugs with FDA-approved NDAs/ANDAs. Supplier identification for SALONPAS typically relies on OTC drug listings, labeling/establishment data, and NDC manufacturer/labeler lines rather than Orange Book.
Which FDA pathways or OTC monograph categories govern SALONPAS and how does that relate to suppliers?
OTC topical analgesics in the US are governed by:
- OTC drug monograph framework and product-specific labeling rules
Supplier assignment is not determined by the pathway itself. It is determined by who is listed as labeler/manufacturer for each NDC configuration.
How many supplier entities are associated with SALONPAS across NDCs?
The supplier count is SKU-dependent. SALONPAS can span multiple NDCs for:
- Different strengths
- Different patch counts per box
- Different regional/package configurations
Without NDCs, an accurate supplier count cannot be produced.
Key Takeaways
- “Suppliers for SALONPAS” cannot be stated accurately without the exact SALONPAS SKU identifiers (at minimum, US NDCs or country product identifiers for each strength and package).
- FDA-linked supplier identification for OTC products is at the NDC labeler/manufacturer level, which varies by formulation and strength.
- A supplier map should be built by NDC-to-manufacturer/labeler mapping and then validated against country-specific product listings.
FAQs
-
How can I identify the SALONPAS manufacturer for a specific box on US shelves?
Use the NDC printed on the carton and match it to the FDA OTC drug listing labeler/manufacturer for that NDC.
-
Do SALONPAS suppliers differ by strength or patch size?
Yes, supplier assignments can differ across strengths, patch dimensions, and package configurations.
-
Is SALONPAS listed in the Orange Book for supplier identification?
Typically not in the same way as prescription products; OTC topical products are usually handled through OTC listings rather than Orange Book.
-
What supplier role matters most for regulatory or compliance purposes?
The FDA-listed manufacturer and labeler for the NDC configuration, since those are the entities tied to product listing and labeling responsibility.
-
Can the brand owner be assumed to be the patch manufacturer?
No. Brand owners often market via distributors or contract manufacturers; exact supplier identification requires SKU-level listing data.
References
- FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
- FDA. National Drug Code Directory (NDC). U.S. Food and Drug Administration. https://ndclist.ndc.fda.gov/ndc/.
